WHO Classification of Tumours Editorial Board (2021) Central Nervous System Tumours WHO Classification of Tumours, 5th Edition, 5th edn. International Agency for Research on Cancer

Van den Bent MJ, Reni M, Gatta G, Vecht C (2008) Oligodendroglioma. Crit Rev Oncol Hematol 66:262–272

Article  PubMed  Google Scholar 

Buckner JC, Shaw EG, Pugh SL et al (2016) Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med 374:1344–1355

Article  PubMed  PubMed Central  Google Scholar 

Yamashita K, Togao O, Kikuchi K et al (2023) Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement. Neuroradiology 65:1415–1418

Article  PubMed  Google Scholar 

Yamashita K, Togao O, Kikuchi K et al (2024) The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods. Neuroradiology 66:187–192

Article  PubMed  Google Scholar 

Weber MA, Zoubaa S, Schlieter M et al (2006) Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66:1899–1906

Article  PubMed  Google Scholar 

Noguchi T, Yoshiura T, Hiwatashi A et al (2008) Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 29:688–693

Article  PubMed  PubMed Central  Google Scholar 

Zeng Q, Jiang B, Shi F, Ling C, Dong F, Zhang J (2017) 3D Pseudocontinuous arterial spin-labeling MR imaging in the preoperative evaluation of gliomas. AJNR Am J Neuroradiol 38:1876–1883

Article  PubMed  PubMed Central  Google Scholar 

Wang N, Xie SY, Liu HM, Chen GQ, Zhang WD (2019) Arterial spin labeling for glioma grade discrimination: correlations with IDH1 genotype and 1p/19q status. Transl Oncol 12:749–756

Article  PubMed  PubMed Central  Google Scholar 

Hatae R, Hata N, Yoshimoto K et al (2016) Precise detection of IDH1/2 and BRAF hotspot mutations in clinical glioma tissues by a differential calculus analysis of high-resolution melting data. PLoS ONE 11:e0160489

Article  PubMed  PubMed Central  Google Scholar 

Yamashita K, Hiwatashi A, Togao O et al (2016) MR imaging-based analysis of glioblastoma multiforme: estimation of IDH1 mutation status. AJNR Am J Neuroradiol 37:58–65

Article  PubMed  PubMed Central  Google Scholar 

Akagi Y, Yoshimoto K, Hata N et al (2018) Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification. Brain Tumor Pathol 35:81–89

Article  PubMed  Google Scholar 

Otsuji R, Hata N, Yamamoto H et al (2024) Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma. Neurooncol Adv 6:vdae069

Higa N, Akahane T, Yokoyama S et al (2020) A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer Sci 111:3902–3911

Article  PubMed  PubMed Central  Google Scholar 

Togao O, Hiwatashi A, Yamashita K et al (2018) Measurement of the perfusion fraction in brain tumors with intravoxel incoherent motion MR imaging: validation with histopathological vascular density in meningiomas. Br J Radiol 91:20170912

Article  PubMed  PubMed Central  Google Scholar 

Kikuchi K, Hiwatashi A, Togao O et al (2017) Correlation between arterial spin-labeling perfusion and histopathological vascular density of pediatric intracranial tumors. J Neurooncol 135:561–569

Article  PubMed  Google Scholar 

Shinozaki N, Uchino Y, Yoshikawa K et al (2011) Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. J Neurosurg 114:1640–1647

Article  PubMed  Google Scholar 

Saito T, Maruyama T, Muragaki Y et al (2013) 11C-methionine uptake correlates with combined 1p and 19q loss of heterozygosity in oligodendroglial tumors. AJNR Am J Neuroradiol 34:85–91

Article  PubMed  PubMed Central  Google Scholar 

Vaquero J, Zurita M, Coca S, Oya S, Morales C (2000) Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas. Surg Neurol 54:229–234; discussion 234

Pietsch T, Valter MM, Wolf HK et al (1997) Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93:109–117

Article  PubMed  Google Scholar 

Kracht LW, Friese M, Herholz K et al (2003) Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 30:868–873

Article  PubMed  Google Scholar 

Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C (2006) Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 129:1884–1891

Article  PubMed  Google Scholar 

Lee YY, Van Tassel P (1989) Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. AJR Am J Roentgenol 152:361–369

Article  PubMed  Google Scholar 

Smits A, Duffau H (2011) Seizures and the natural history of World Health Organization Grade II gliomas: a review. Neurosurgery 68:1326–1333

Article  PubMed  Google Scholar 

Saito T, Muragaki Y, Maruyama T et al (2016) Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas. Brain Tumor Pathol 33:175–182

Article  PubMed  Google Scholar 

Feinberg DA, Günther M (2009) Cerebral blood flow imaging with 3D GRASE ASL sequence increases SNR and shortens acquisition time. Magnetom Flash 3:62–69

Google Scholar